Ironwood Pharmaceuticals Inc (FRA:I76)
€ 4.5 -0.04 (-0.88%) Market Cap: 713.95 Mil Enterprise Value: 1.21 Bil PE Ratio: 0 PB Ratio: 0 GF Score: 56/100

Ironwood Pharmaceuticals Inc at JPMorgan Healthcare Conference Transcript

Jan 10, 2024 / 07:15PM GMT
Release Date Price: €11.3 (-2.59%)
Ethan Taylor
JPMorgan Chase & Co. - Analyst

Hello, everyone. Welcome to the Ironwood Pharmaceuticals company presentation. My name is Ethan Taylor, I'm an associate in JPMorgan's healthcare investment banking group. It is my pleasure to introduce the Ironwood management team and Tom McCourt, CEO of Ironwood Pharmaceuticals. A quick reminder, there will be time towards the end of the presentation for some audience Q&A, so please have some questions ready. And with that, Tom, please take it away.

Tom McCourt
Ironwood Pharmaceuticals, Inc. - CEO

Thanks, Ethan. I just want to start off by thanking JP Morgan for allowing us to participate in the conference this year. It's been a really wonderful few days. The level of interest that we're getting from the investment community has been really remarkable. And I really appreciate everybody participating. With me today is Sravan Emany, our Chief Financial Officer; and Dr. Mike Shetzline, who is our Chief Medical Officer. And let's get started. So this is our disclosures -- is it showing up? Okay, so this our

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot